Shares of Amdocs Limited (NASDAQ:DOX – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $101.20.
Several research firms have recently weighed in on DOX. Oppenheimer boosted their price objective on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Stifel Nicolaus initiated coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target on the stock. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 14th. Finally, Barclays decreased their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th.
Read Our Latest Stock Report on Amdocs
Institutional Trading of Amdocs
Amdocs Stock Up 1.0 %
Amdocs stock opened at $87.01 on Monday. The firm has a market capitalization of $9.82 billion, a PE ratio of 20.52, a P/E/G ratio of 1.45 and a beta of 0.72. The company’s 50-day moving average is $87.93 and its 200-day moving average is $84.86. Amdocs has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.24.
Amdocs Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Tuesday, December 31st. Amdocs’s dividend payout ratio is currently 45.05%.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- Airline Stocks – Top Airline Stocks to Buy Now
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Breakout Stocks: What They Are and How to Identify Them
- CarMax Gets in Gear: Is Now the Time to Buy?
- Consumer Staples Stocks, Explained
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.